TD Asset Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-85,800
Closed -$2.6M 1195
2025
Q1
$2.6M Sell
85,800
-384,600
-82% -$14.7M ﹤0.01% 903
2024
Q4
$18.7M Hold
470,400
0.02% 523
2024
Q3
$29.8M Sell
470,400
-125,200
-21% -$9.04M 0.03% 409
2024
Q2
$40.2M Sell
595,600
-39,400
-6% -$2.75M 0.04% 330
2024
Q1
$50.3M Buy
635,000
+29,800
+5% +$2.44M 0.05% 308
2023
Q4
$47.1M Buy
605,200
+49,600
+9% +$3.67M 0.05% 301
2023
Q3
$39.1M Hold
555,600
0.05% 296
2023
Q2
$44.2M Buy
555,600
+41,600
+8% +$3.01M 0.05% 286
2023
Q1
$37.1M Sell
514,000
-97,000
-16% -$7.56M 0.04% 313
2022
Q4
$50.3M Sell
611,000
-151,000
-20% -$12.4M 0.06% 254
2022
Q3
$60.9M Sell
762,000
-23,800
-3% -$1.9M 0.08% 202
2022
Q2
$53.1M Sell
785,800
-20,200
-3% -$1.41M 0.06% 246
2022
Q1
$52.8M Sell
806,000
-50,000
-6% -$2.9M 0.05% 282
2021
Q4
$52M Buy
856,000
+434,500
+103% +$25.9M 0.04% 320
2021
Q3
$26.9M Buy
421,500
+6,200
+1% +$391K 0.03% 407
2021
Q2
$25.6M Buy
415,300
+22,300
+6% +$1.4M 0.03% 424
2021
Q1
$22.5M Buy
393,000
+66,000
+20% +$3.57M 0.03% 437
2020
Q4
$16.4M Buy
327,000
+45,000
+16% +$1.79M 0.02% 472
2020
Q3
$8.31M Sell
282,000
-22,078
-7% -$641K 0.01% 585
2020
Q2
$7.64M Sell
304,078
-44,960
-13% -$1.12M 0.01% 569
2020
Q1
$6.41M Buy
349,038
+5,600
+2% +$160K 0.01% 571
2019
Q4
$11.4M Sell
343,438
-200
-0.1% -$6.27K 0.02% 519
2019
Q3
$10.7M Buy
343,638
+19,866
+6% +$605K 0.02% 499
2019
Q2
$11.3M Buy
323,772
+49,000
+18% +$1.58M 0.02% 491
2019
Q1
$8.05M Buy
274,772
+6,200
+2% +$176K 0.01% 573
2018
Q4
$6.91M Sell
268,572
-15,651
-6% -$542K 0.01% 574
2018
Q3
$10M Buy
284,223
+20,900
+8% +$833K 0.01% 536
2018
Q2
$10.8M Buy
263,323
+12,800
+5% +$516K 0.02% 512
2018
Q1
$9.81M Buy
250,523
+54,600
+28% +$2M 0.02% 525
2017
Q4
$6.39M Sell
195,923
-5,633
-3% -$195K 0.01% 619
2017
Q3
$9.63M Sell
201,556
-11,255
-5% -$549K 0.01% 522
2017
Q2
$10.5M Sell
212,811
-2,639
-1% -$117K 0.02% 510
2017
Q1
$9.39M Buy
215,450
+2,500
+1% +$101K 0.02% 546
2016
Q4
$7.05M Buy
212,950
+14,900
+8% +$578K 0.01% 598
2016
Q3
$9.81M Buy
198,050
+28,900
+17% +$1.51M 0.02% 536
2016
Q2
$9.37M Sell
169,150
-1,000
-0.6% -$58.5K 0.02% 528
2016
Q1
$9.38M Buy
170,150
+94,900
+126% +$5.42M 0.02% 513
2015
Q4
$4.7M Sell
75,250
-1,100
-1% -$71.7K 0.01% 676
2015
Q3
$5.06M Buy
76,350
+35,700
+88% +$2.75M 0.01% 625
2015
Q2
$3.18M Sell
40,650
-1,200
-3% -$86.4K 0.01% 791
2015
Q1
$3M Buy
41,850
+2,100
+5% +$135K 0.01% 780
2014
Q4
$2.43M Buy
39,750
+2,950
+8% +$172K ﹤0.01% 813
2014
Q3
$1.78M Buy
36,800
+2,100
+6% +$103K ﹤0.01% 840
2014
Q2
$1.58M Buy
34,700
+6,300
+22% +$277K ﹤0.01% 852
2014
Q1
$1.28M Sell
28,400
-8,400
-23% -$414K ﹤0.01% 875
2013
Q4
$1.74M Sell
36,800
-2,500
-6% -$109K ﹤0.01% 825
2013
Q3
$1.55M Sell
39,300
-10,300
-21% -$382K ﹤0.01% 826
2013
Q2
$1.64M Buy
+49,600
New +$1.61M ﹤0.01% 792

Other funds holding ACHC

TD Asset Management's ACHC Position: Q2 2025 in Review

TD Asset Management sold out of Acadia Healthcare (ACHC) in Q2 2025, closing a stake of 85,800 shares — an estimated $2.6M sold.

TD Asset Management first reported a position in ACHC in Q2 2013 and held it in 48 quarters. The position peaked at $60.9M in Q3 2022. 293 funds tracked by Wall St. Rank hold ACHC as of Q2 2025.

  • TD Asset Management reported no remaining Acadia Healthcare position as of Q2 2025 after selling out during the quarter.
  • TD Asset Management sold 85,800 Acadia Healthcare shares in Q2 2025, an estimated $2.6M.
  • TD Asset Management first reported a position in Acadia Healthcare in Q2 2013 and held it in 48 quarters.
  • TD Asset Management's Acadia Healthcare position peaked at $60.9M in Q3 2022.
  • 293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2025.

Based on TD Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.